2020-2027 Analysis and Review Methadone Hydrochloride Market

Methadone Hydrochloride Market

Methadone Hydrochloride Market By Clinical Application (Pain Management Therapy and Opioid Addiction Treatment), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

15-03-2020 REP-HC-5050 40 Tables 116 pages Format

The methadone hydrochloride market was valued at USD5,915.2Mn by 2019. As per the latest information provided by the United Nations Office on Drug and Crime (UNODC), in 2017 approximately 12.9 million people worldwide were reported to be addicted to heroin. Increasing demand for methadone hydrochloride as a medicinal drug for opioid addiction treatment and chronic pain management together drives its market growth.

 Methadone Hydrochloride Market

Methadone hydrochloride.is classified as a mu receptor agonist present in the central nervous system, which is used in multiple formulation and concentrations of 5mg/5ml, 10mg/ml for oral administration, and 10mg/ml solution for parenteral administration.

The major segments related to the methadone hydrochloride market are:

By Clinical Application (2017–2027; US$ Mn)

Pain Management Therapy

Opioid Addiction Treatment

By Distribution Channel (2017–2027; US$ Mn)

Hospital Pharmacy

Retail Pharmacy

Others

Geography Segment(2017–2027; US$ Mn)

North America

United States
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global methadone hydrochloride market
  • The overall segmentation of the methadone hydrochloride market, by clinical application, distribution channel, and geography is minutely studied. Opioid addiction treatment and hospital pharmacy are dominating the clinical application and distribution channel segments respectively
  • A constant rise in the number of patients addicted to opioid and narcotic drugs
  • Rising prevalence of cancer and musculoskeletal disorders requiring pain management therapy

Report gist?

  • The study of the global methadone hydrochloride market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers qualitative and quantitative analysis of the overall market segmented on the basis of clinical application and distribution channel and categorization of the same at the geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. Compounded annual growth rate is calculated for the respective segments from 2020 to 2027
  • The study includes the profiles of major market players with a significant global and regional presence along with top company positioning

Significant customers?

  • This study is suitable for industry participants and stakeholders in the pharmaceutical companies engaged in the manufacturing and marketing of methadone hydrochloride which is gaining huge traction owing to its ability to treat opioid addiction and in pain management
  • The report will benefit physicians engaged in the prescription of methadone hydrochloride to treat acute and chronic pain
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to methadone hydrochloride market
  • Financial institutions venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies

Segment Analysis

Opioid addiction treatment is leading the largest market share in the clinical application segment for the methadone hydrochloride market. Opioid misuse means the narcotic drugs are taken without medical supervision and doctor’s prescription. Addiction is a chronic brain disease that causes cravings of narcotic drugs especially during the withdrawal symptoms. The increasing trend of using heroin and other ecstasy drugs during social gatherings is causing a significant rise in drug abuse cases worldwide. As per the research citings presented by the World Health Organization (WHO) each year approximately 15 million throughout the globe are suffering from opioid addiction. Methadone hydrochloride oral administration of 5 mg or 10 mg for a few weeks is helpful in the opioid addiction management and treatment. Pain management therapy is gaining huge traction owing to the rising prevalence of cancer patients worldwide suffering from chronic pain. Methadone hydrochloride and NSAIDS are used in combination with pain management therapy in medical conditions such as joint disorders, back pain, surgery, arthritis, etc.

Hospital pharmacy is currently dominating the distribution channel segment for the methadone hydrochloride market. Hospital pharmacist is essential in adjusting the methadone hydrochloride dose in the opioid addiction management and detoxification therapy. It is under government regulation and is available on prescription in the hospital pharmacy of developed regions. Retail pharmacy is anticipated to grow at a comfortable pace during the forecast period on account of the availability of different combinations and compositions of methadone hydrochloride generic versions to manage chronic patients in poor patients suffering from occupational hazard associated joint disorders.

North America is currently ruling the geography segment for the methadone hydrochloride market. The rising prevalence of opioid addiction primarily drives its market growth. As per the latest research citings brought forward by the National Institute of Health, approximately 2 million Americans are reported to misuse prescription opioids and heroin each year. The economic burden associated with the opioid prescription in the United States is about 78.5 billion dollars. Additionally the presence of major players such as Eli Lilly & Company, Mallinckrodt Pharmaceuticals, Aurolife Pharma, LLC, etc. further propel the market growth. Europe is in the 2nd place in the regional segment on account of the rising prevalence of cancer patients suffering from chronic pain. As per the statistics brought forward by the World Health Organization (WHO), in 2019, approximately 3.7 million new cancer cases were reported in the European region. Affordable reimbursement scenario for the methadone hydrochloride formulation employed in pain management therapy accentuates its market growth in the region. The Asia Pacific is going to register rapid market growth in the near future owing to the rising prevalence of the geriatric population suffering from a musculoskeletal disorders associated with chronic pain and the presence of an established generic drug market.

Select License Type

$4,600
$6,600
$9,500

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.